Diagnosing concussions may soon be as simple as ordering blood tests

Medical investigators just got one step closer to finding the “holy grail for head injury research,” in the words of Walter Koroshetz, director of the NIH’s National Institute of Neurological Disorders and Stroke.

He’s talking about a biomarker for concussions easily detectable in a blood test, which Orlando Health researchers suggested is worth pursuing after their study showed that a protein linked with head trauma may be present in blood up to a week after injury.

Many people affected by head trauma put off getting diagnosed because of time and trouble concerns.

The availability of a low-hassle blood test, which the researchers point out is still quite a ways off, might negate much of the procrastination.

JAMA Neurology published the study March 28.

US News & World Report was among the outlets that picked up AP’s reporting on the development:

Dave Pearson

Dave P. has worked in journalism, marketing and public relations for more than 30 years, frequently concentrating on hospitals, healthcare technology and Catholic communications. He has also specialized in fundraising communications, ghostwriting for CEOs of local, national and global charities, nonprofits and foundations.

Around the web

RBMA President Peter Moffatt discusses declining reimbursement rates, recruiting challenges and the role of artificial intelligence in transforming the industry.

Deepak Bhatt, MD, director of the Mount Sinai Fuster Heart Hospital and principal investigator of the TRANSFORM trial, explains an emerging technique for cardiac screening: combining coronary CT angiography with artificial intelligence for plaque analysis to create an approach similar to mammography.

A total of 16 cardiology practices from 12 states settled with the DOJ to resolve allegations they overbilled Medicare for imaging agents used to diagnose cardiovascular disease.